As it promised last month, Bayer, the world's largest seed and agricultural chemicals company, asked the U.S. Supreme Court on Monday to overturn the $25-million award to Edwin Hardeman, a California man who blamed Roundup herbicide for giving him cancer. The appeal is a key element in Bayer's plan to resolve billions of dollars of claims against Roundup and its active ingredient, glyphosate, the most widely used weedkiller in the world.
Health and chemical giant Bayer said it would pursue a five-point plan to mitigate its future litigation risks over Roundup herbicide, including a discussion of whether to remain in the lawn-and-garden market and a continued pursuit of settlements of lawsuits that allege the weedkiller causes cancer.
In its second proposal to settle future lawsuits that allege its Roundup weedkiller is carcinogenic, seed and ag-chemical giant Bayer said on Wednesday that it would pay up to $200 million to individual claimants and a maximum of $2 billion overall to cover lawsuits filed in the next four years.
The herbicide dicamba is too risky to use on row crops such as soybeans and cotton until independent research shows it won't evaporate and harm nearby crops and plants, said a report from three conservation and environmental groups on Wednesday. Dicamba is blamed for "off-target" damage on millions of acres of property, and the EPA is considering possible rules for its use on crops in the future.
The fast-growing weed Palmer amaranth has developed a tolerance for dicamba herbicide in least five counties in western Tennessee and likely several others, said University of Tennessee weed specialist Larry Steckel on Monday. The report was a setback for dicamba, which was introduced a few years ago as a new tool for control of invasive weeds that showed resistance to glyphosate and other weedkillers.
Two weeks after agreeing to pay up to $9.6 billion to resolve thousands of cancer lawsuits against glyphosate, seed and ag-chemical giant Bayer is still looking for a way to handle future litigation against the weedkiller. A proposal to appoint a panel of experts to decide if glyphosate is carcinogenic — a pivotal question for cases filed in coming years — died on Wednesday following criticism from the federal judge handling the lawsuits.
Under the terms of an agreement announced Wednesday, seed and agribusiness giant Bayer will pay up to $10.9 billion to resolve lawsuits that accuse its Roundup herbicide of causing cancer, and an additional $400 million to settle litigation claiming crop damage caused by its dicamba weedkiller from 2015 to 2020.
Glyphosate, the most widely used herbicide in the world, poses no threat to human health when used as directed and is unlikely to cause cancer, said the EPA in an interim decision on Thursday. Environmental groups denounced the decision as faulty.
Chiding California regulators for "misleading labeling requirements," the EPA told herbicide makers to remove cancer warnings from containers of glyphosate, the most widely used weedkiller in the world, in a step that would benefit seed and ag chemical giant Bayer. Meanwhile, a court-appointed mediator dismissed as "pure fiction" a report that the German company offered $8 billion to settle all U.S. lawsuits against Roundup, Bayer's glyphosate-based herbicide.